IRIS
FRIES, Walter
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.440
EU - Europa 4.146
AS - Asia 814
OC - Oceania 10
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 9.417
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.428
SE - Svezia 1.195
IE - Irlanda 1.166
CN - Cina 651
UA - Ucraina 359
DE - Germania 328
FR - Francia 287
IT - Italia 246
GB - Regno Unito 220
FI - Finlandia 188
SG - Singapore 104
PL - Polonia 77
IN - India 33
RU - Federazione Russa 27
BE - Belgio 24
CA - Canada 10
AU - Australia 8
VN - Vietnam 8
NL - Olanda 7
AT - Austria 4
ES - Italia 4
CH - Svizzera 3
EU - Europa 3
IL - Israele 3
IR - Iran 3
JP - Giappone 3
RO - Romania 3
BR - Brasile 2
CL - Cile 2
CZ - Repubblica Ceca 2
HK - Hong Kong 2
ID - Indonesia 2
MX - Messico 2
NZ - Nuova Zelanda 2
DK - Danimarca 1
EE - Estonia 1
IQ - Iraq 1
KR - Corea 1
LV - Lettonia 1
ME - Montenegro 1
NO - Norvegia 1
NP - Nepal 1
RS - Serbia 1
SA - Arabia Saudita 1
UZ - Uzbekistan 1
Totale 9.417
Salva come PNG Salva come JPEG
Città #
Dublin 1.166
Chandler 953
Jacksonville 762
Nyköping 509
Beijing 264
Ashburn 246
Princeton 220
Dearborn 191
Cambridge 183
Des Moines 173
Medford 143
Lancaster 117
Boardman 112
Ann Arbor 94
Woodbridge 69
Messina 64
Warsaw 64
Jinan 57
Singapore 57
Wilmington 52
Bremen 50
Shenyang 49
San Mateo 42
Los Angeles 29
Seattle 29
Hebei 26
Tianjin 26
Zhengzhou 25
Ningbo 24
Brussels 23
Houston 21
Nanjing 21
Haikou 19
Hangzhou 17
Washington 16
Helsinki 15
Jiaxing 14
Nanchang 13
Changsha 12
Hyderabad 12
Munich 12
Taizhou 12
Rome 11
Pune 10
Falls Church 9
Fuzhou 9
Milan 9
Redwood City 9
Catania 8
Dong Ket 8
Kunming 8
Guangzhou 7
Saint Petersburg 7
Augusta 6
Carini 6
Norwalk 6
Taiyuan 6
Hefei 5
Lanzhou 5
Milazzo 5
Mountain View 5
New York 5
Tappahannock 5
Barcelona 4
Hanover 4
Lappeenranta 4
Leawood 4
Trecastagni 4
Turin 4
Vienna 4
Vittoria 4
Albany 3
Auburn Hills 3
Belluno 3
Brisbane 3
Chicago 3
Clearwater 3
Ficarra 3
Islington 3
Kemerovo 3
London 3
Mineo 3
Padova 3
Palermo 3
Riva 3
Salerno 3
Amsterdam 2
Ardabil 2
Bari 2
Berlin 2
Brooklyn 2
Campobasso 2
Enna 2
Frankfurt am Main 2
Gurgaon 2
Harrow 2
Hong Kong 2
Jakarta 2
Kolkata 2
Mexico City 2
Totale 6.257
Salva come PNG Salva come JPEG
Nome #
Combined approach with biologics and surgery for entero-cutaneous fistulas in Crohn’s disease 103
Association between inflammatory bowel disease and sarcoidosis. Report of two cases and review of the literature 88
Optical coherence tomography evaluation of ulcerative colitis: The patterns and the comparison with histology 83
Metacognitions and basic emotions in patients with irritable bowel syndrome and inflammatory bowel disease 81
Mucosal healing in inflammatory bowel disease: Maintain or de-escalate therapy. 79
A three year pilo study with 1,25 dihydroxyvitamin D, calcium and calcitonin for severe osteodystrophy in primary biliary cirrhosis 77
Urinary neutrophil gelatinase-associated lipocalin (uNGAL) levels in patients with Crohn’s disease undergoing treatment with infliximab. 73
Late-onset Crohn's disease: a comparison of disease behaviour and therapy with younger adult patients: the Italian Group for the Study of Inflammatory Bowel Disease 'AGED' study 73
Response evaluation and safety of thiopurines in the treatment of inflammatory bowel diseases (IBD): safety and response evaluation. 70
Azathioprine/6-Mercaptopurine in the treatment of inflammatory bowel disease (IBD)- A single centre experience 69
Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease after Ileocolonic Resection 68
Early Post-Operative Endoscopic Recurrence in Crohn's Disease in an Italian Multicentric Cohort. 67
Efficacy and Safety of Oral Beclomethasone Dipropionate in Ulcerative Colitis: A Systematic Review and Meta-Analysis. 67
Azathioprine/6-Mercaptopurine in the treatment of inflammatory bowel disease (IBD)- A single centre experience. 66
Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease: a prospective study. 66
IBD-associated bone loss: is inflammation the explanation? 65
A protective effect of the synthetic coumarine derivative cloricromene on DNB-colitis in the rat. 64
Clinical significance of NOD2/CARD15 and Toll-like receptor 4 gene single nucleotide polymorphisms in inflammatory bowel disease. 64
Vitamin D and inflammatory bowel disease 64
Negative emotions in irritable bowel syndrome: which differences among IBS subtypes? 64
A Prospective Comparison Between Computerized Tomography (CT) and Magnetic Resonance (MR) in Ileo-Colonic Crohn's Disease: A Single-Center Experience. 63
Prevention of post-surgical recurrence with adalimumab in a patient with complicated Crohn's disease. 63
The aged gut in inflammatory bowel diseases. 63
Hepatocyte tight-junctional permeability is increased in rat experimental colitis. 62
Microradiographic anatomy of the explanted rat colon 62
Association between previously identified disease loci at chr12q15 and chr1p36 and UC in Italian population 62
Ileal tight junction (TJ) alterations associated with experimental colitis – a time course. 62
Quality of life after proctocolectomy and ileo-anal anastomosis for severe ulcerative colitis 61
Oral beclomethasone diproprionate in pediatric active ulcerative colitis: a comparison trial with mesalazine. 61
Le porfirie 60
Anti-TNF therapy in elderly people in IBD; an Italian multicentre survey 60
Guide to magnetic resonance in Crohn's disease: from common findings to the more rare complicances. 60
H1N1 vaccines in a large observational cohort of patients with inflammatory bowel disease treated with immunomodulators and biologics. 60
OCT Performance in the Diagnosis of Ulcerative Colitis 59
Anti-TNF Therapy in Elderly People in IBD: An Italian Multicentre Survey. 59
Fecal calprotectin correlates with intestinal permeabilità (IP) in patients with Crohn’s disease. 59
Age is a Risk Factor for Severe Infections and Mortality in Patients given Anti-Tumor Necrosis Factor Therapy for Inflammatory bowel disease. 59
Thiopurine treatment in inflammatory bowel disease: response predictors, safety and withdrawal in follow-up. 59
Association Between Previously Identified Disease Loci At Chr12q15 and Chr1p36 and UC in Italian Population. 58
A “real life” experience of infliximab use for Crohn’s disease in southern Italy 58
Bone metabolism in orthotopic liver transplantation: a prospective study 57
Gastric fundectomy in the rat - effects on mineral bone metabolism, with emphasis on the gastrin-calcitonin-parathyroid hormone-vitamin D axis 57
Infliximab normalizes intestinal permeability in the short-term but not fecal calprotectin in Crohn’s disease 57
Thalidomide for refractory bleeding small intestinal Crohn’s disease– a case report 57
Hemophagocytic lymphohistiocytic (HLH) syndrome in IBD patients treated with thiopurines – a case series 57
Comparative Efficacy of Vedolizumab and Adalimumab in Ulcerative Colitis Patients Previously Treated With Infliximab 57
Outcome in ulcerative colitis after switch from adalimumab/golimumab to infliximab: A multicenter retrospective study 57
Treatment with a glycosaminoglycan formulation ameliorates experimental diabetic nephropathy. 56
Gastric permeability of sucrose is increased in portal hypertensive gastropathy. 56
Inflammatory Bowel Disease in the Elderly – Knowledge Gaps and Potential Directions in Research 56
GASTROINTESTINAL PERMEABILITY IS INCRISED IN SCLERODERMA PATIENTS 55
Clinical significante of NOD2/CARD15 and TLR4 gene SNPs in inflammatory bowel disease 55
Disease patterns in late-onset ulcerative colitis: Results from the IG-IBD “AGED study” 55
The Optical Coherence Tomography in Inflammatory Bowel Disease (IBD): Prospective Evaluation of 35 Patients 54
Therapy-related adverse events in Crohn’s disease (CD) – a comparison between thiopurines, infliximab and combined therapy. 54
The PROSIT Cohort of Infliximab Biosimilar in IBD: A Prolonged Follow-up on the Effectiveness and Safety Across Italy 54
Osteopenia following total gastrectomy in the rat - state of mineral metabolism and bone histomorphometry 53
Analisi molecolare dei geni TLR4 e CARD15/NOD2 in pazienti affetti da malattie infiammatorie croniche intestinali: dati preliminari in una popolazione del sud Italia 53
Thiopurines in the treatment of inflammatory bowel diseases – a single centre experience. 53
Clinical practice in the management of ulcerative colitis - an Italian survey 52
Treatment of life threatening type I refractory celiac disease with long term infliximab 52
Experimental colitis increases small intestine permeability in the rat 52
Leukocyte traffic control: a novel therapeutic strategy for inflammatory bowel disease 52
Cytomegalovirus complicating Inflammatory Bowel Disease: Useful Remarks. 52
Efficacy and safety of long-term infliximab use for Crohn’s disease in Southern Italy. 51
Contenuti metacognitivi e alessitimia in un gruppo di soggetti con disturbi gastrointestinali. Uno studio esplorativo 51
Turnover osseo e sistema osteoprotegerina/RANKL nell'osteodistrofia epatica 50
TNF-alpha inhibition prevents early tight junction rearrangement and apoptosis of ileal enterocytes in experimental colitis. 50
Diagnostic accuracy of faecal calprotectin in a symptom-based algorithm for early diagnosis of inflammatory bowel disease adjusting for differential verification bias using a Bayesian approach 50
Effect of experimental colitis on bone metabolism in the rat 49
TNF-ALPHA INHIBITION PREVENTS EARLY TIGHT JUNCTION REARRANGEMENT AND APOPTOSIS OF ILEAL ENTEROCYTES IN EXPERIMENTAL COLITIS. 49
Infliximab and etanercept are equally effective in reducing enterocyte apoptosis in experimental colitis. 49
Gastric permeability to sucrose is increased in portal hypertensive gastropathy 49
Predicting response to thiopurines – a single centre experience. 49
Dysfunctional metacognitive beliefs and gastrointestinal disorders. Beyond an ‘organic’/‘functional’ categorization in the clinical practice. 49
The effect of heparin on trinitrobenzene sulphonic acid-induced colitis in the rat 48
Gastro-intestinal permeability is increased in patients with limited systemic sclerosis 48
A protective effect of the synthetic coumarine derivative Cloricromene against DNB-colitis in the rat 48
Intestinal permeability and genetic determinants in patients, first degree relatives and controls in a high incidence area of Crohn’s disease. 48
Celiac disease (CD) in inflammatory bowel diseases (IBD): a preliminary result of a prevalence study. 48
Mucosal Immunology and Probiotics. 48
Bone density and calcium metabolism in patients with long standing, quiescent Crohn's disease 47
Extra-gastric effects of highly selective vagotomy. Bone and mineral metabolism in the rat. 47
Omega-3 polyunsaturated fatty acids reduce bone loss in experimental colitis. 47
Effects of anti COX-2, nabumetone and aspirin on gastric and intestinal permeability on healthy volunteers 47
Safety of a (H1N1)V Vaccine in patients with inflammatory bowel disease treated with immunomodulators and biologicals 47
Adalimumab In Active Ulcerative Colitis: A “Real-Life” Observational Study on behalf of the Italian Group for the study of Inflammatory Bowel Disease. 47
A propensity score-matched comparison of infliximab and adalimumab in TNF-α inhibitors naïve and non-naïve patients with Crohn's disease: real-life data from the Sicilian Network for Inflammatory Bowel Disease (SN-IBD) 47
Infliximab: effetto su nutrizione e permeabilità intestinale 46
Use of alternative and complementary medicine in Italian patients with Inflammatory Bowel Disease 46
Mast cells mediate stress-induced loss of ileal tight junction (TJ)-permselectivity in the rat. 46
Direct oral anticoagulants increase the risk of anaemia and hospitalization in IBD patients with active intestinal disease 46
Efficacy and safety of long-term infliximab use for Crohn’s disease in Southern Italy. 45
Dysfunctional metacognitive beliefs and gastrointestinal disorders. Beyond an ‘organic’/‘functional’ categorization in the clinical practice 45
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy 45
Effectiveness and safety of vedolizumab in biologically naïve patients: A real-world multi-centre study 45
One-year effectiveness and safety of ustekinumab in ulcerative colitis: a multicenter real-world study from Italy 45
Vagus-sparing fundectomy in the rat - development of osteopenia, relationship to urinary phosphate and net acid secretion, serum gastrin and vitamin D 44
Oral propranolol decreases intestinal permeability in patients with cirrhosis: another protective mechanism against bleeding? 44
Evolution of osteopenia in inflammatory bowel disease 43
Totale 5.677
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.069
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.069
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.309 0 75 14 57 24 214 214 221 42 191 232 25
2020/20211.432 157 25 329 100 110 166 57 116 23 156 107 86
2021/20221.422 8 191 30 42 45 15 62 46 15 337 196 435
2022/20233.433 304 280 156 303 288 323 39 178 1.418 17 91 36
2023/2024798 70 117 88 133 89 103 21 30 2 69 8 68
2024/2025111 64 47 0 0 0 0 0 0 0 0 0 0
Totale 9.787